MDLN

시간 외 거래: 44.75 0.20 +0.45%

Medline Inc (MDLN)

개요 뉴스 가격 이력 토론 예측

Relative Volume:

Medline Inc Stock (MDLN) Company Profile

Healthcare (1111)

최신 SEC 제출 서류

MDLN's Discussions on Twitter

Compare MDLN vs ISRG, BDX, ALC, RMD

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
MDLN Medline Inc	44.55	37.11B	27.43B	1.27B	1.01B	1.5829
ISRG Intuitive Surgical Inc	485.84	169.97B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	175.89	50.58B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	79.20	38.58B	10.19B	1.05B	1.38B	2.1044
RMD Resmed Inc	252.55	35.80B	5.40B	1.49B	1.78B	10.12

Medline Inc Stock (MDLN) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2026-02-05	개시	Tigress Financial	Buy
2026-01-21	재확인	BTIG Research	Buy
2026-01-12	개시	Citigroup	Buy
2026-01-12	개시	Deutsche Bank	Hold
2026-01-12	개시	Evercore ISI	Outperform
2026-01-12	개시	Goldman	Buy
2026-01-12	개시	JP Morgan	Overweight
2026-01-12	개시	Jefferies	Buy
2026-01-12	개시	Leerink Partners	Outperform
2026-01-12	개시	Mizuho	Outperform
2026-01-12	개시	Morgan Stanley	Overweight
2026-01-12	개시	Piper Sandler	Overweight
2026-01-12	개시	RBC Capital Mkts	Outperform
2026-01-12	개시	Robert W. Baird	Outperform
2026-01-12	개시	Rothschild & Co Redburn	Neutral
2026-01-12	개시	Stifel	Buy
2026-01-12	개시	TD Cowen	Buy
2026-01-12	개시	Truist	Buy
2026-01-12	개시	UBS	Buy
2026-01-12	개시	Wells Fargo	Equal Weight
2026-01-12	개시	William Blair	Outperform
2026-01-12	개시	Wolfe Research	Outperform

Medline Inc 주식(MDLN)의 최신 뉴스

Medline Inc (MDLN) 재무 분석

Medline Inc 주식 (MDLN) 내부자 거래

내부자 거래	관계	날짜	거래	비용	#주식	가치 ($)	#주식 총계
GIC Private Ltd	10% Owner	Dec 18 '25	Buy	29.00	12,586,206	364,999,974	27,241,378
GIC Private Ltd	10% Owner	Dec 18 '25	Sale	28.37	10,204,351	289,480,090	91,555,447
TC Group VII S1, L.L.C.	10% Owner	Dec 18 '25	Sale	29.00	19,136,333	554,953,657	145,924,924
Carlyle Mozart Coinvestment Ho	10% Owner	Dec 18 '25	Sale	29.00	19,136,333	554,953,657	145,924,924
Carlyle Group Inc.	10% Owner	Dec 18 '25	Sale	29.00	19,136,333	554,953,657	145,924,924
Mozart Aggregator II LP	10% Owner	Dec 18 '25	Sale	28.37	13,462,600	381,911,076	143,187,216
Mills Andrew J.	Director	Dec 18 '25	Buy	29.00	2,586,206	74,999,974	2,586,206
Mills Charles N.	Director	Dec 18 '25	Buy	29.00	2,579,310	74,799,990	2,441,379

Medline Inc (MDLN)

Medline Inc Stock (MDLN) Company Profile

Compare MDLN vs ISRG, BDX, ALC, RMD

Medline Inc Stock (MDLN) Upgrades & Downgrades

Medline Inc 주식(MDLN)의 최신 뉴스

FDA Flags Serious Safety Fire Risks In Medline Homecare Beds - Benzinga

Is It Too Late To Consider Medline (MDLN) After Its Recent Share Price Rally? - Yahoo Finance

Medline stock pops 40% in first trading session after company raises $6.3 billion in 2025's biggest IPO - AOL.com

Evaluating Medline (MDLN) After Recent Share Price Momentum And A 31.1x P/E Multiple - Sahm

Medline Inc. (MDLN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Medline Inc.Class A common stock (NQ: MDLN - FinancialContent

MDLN Medline Inc. Feb 2026 Tigress Financial Initiates Coverage with Buy - Meyka

Tigress Financial initiates Medline stock with Buy rating, $55 target By Investing.com - Investing.com Nigeria

Tigress Financial initiates Medline stock with Buy rating, $55 target - Investing.com

Medline (NASDAQ:MDLN) Now Covered by Analysts at Tigress Financial - MarketBeat

Tigress Initiates Medline at Buy With $55 Price Target - marketscreener.com

How the Largest IPO of 2025 Could Be Healthy for Your Portfolio - The Motley Fool

Wash. Justices Won't Hear Medline's $2.4M Refund Request - Law360

Medline CEO Jim Boyle talks record IPO and AI plans with hospitals - Crain's Chicago Business

Medline’s Jim Boyle talks record IPO, AI plans with hospitals - Modern Healthcare News

Medline to report fourth quarter and full year 2025 results on February 25, 2026 - GlobeNewswire

Is It Time To Reassess Medline (MDLN) After Its Recent Share Price Climb - Yahoo Finance

Medline Inc (MDLN) Shares Up 3.65% on Jan 22 - GuruFocus

Jim Cramer says Medline stock is unbelievable and recommends buying it - MSN

Jim Cramer Says Medline "Stock Is Unbelievable" And Recommends Buying It - Finviz

Medline Industries: Solid Physical Moat With Visible Earnings Growth Runway (NASDAQ:MDLN) - Seeking Alpha

Jim Cramer Recently Looked at These 25 Stocks - Insider Monkey

Is There An Opportunity In Medline (MDLN) After Recent DCF Valuation Results - Sahm

Pointcore Supply Chain Services members select Medline as distributor - Medline Newsroom

Ranpak expands packaging automation partnership with Medline - Packaging Insights

In face of uncertainty and tariffs, newly public Medline sticks to the old formula - Crain's Chicago Business

Ranpak and Medline deepen packaging automation collaboration - Yahoo Finance

Ranpak in Collaboration with Medline - Medical Device and Diagnostic industry

Medline Shares Climb as Analysts Launch Coverage After $7.2 Bill - GuruFocus

Medline Shares Climb as Analysts Launch Coverage After $7.2 Billion IPO - Yahoo Finance

Ranpak and Medline Partner to for High-Volume Distribution Operations From: Ranpak Corporation - Healthcare Packaging

Ranpak Holdings Corp. and Medline Partner to Advance Automation and Sustainable Packaging Across High-Volume Distribution Operations - marketscreener.com

Ranpak and Medline Partner to Advance Automation and Sustainable Packaging Across High-Volume Distribution Operations - Business Wire

Analysts Are Bullish on These Healthcare Stocks: Exagen (XGN), Medline, Inc. Class A (MDLN) - The Globe and Mail

Analysts Offer Insights on Healthcare Companies: Medline, Inc. Class A (MDLN) and IDEAYA Biosciences (IDYA) - The Globe and Mail

Medline jumps as analysts bullish after 2025’s top IPO - The Daily Gazette

Medline Jumps as Analysts Bullish After 2025’s Top IPO - Bloomberg

Analysts initiate coverage on Medline after IPO, flag growth visibility and margin - Investing.com

Why Is Medline Stock Gaining Monday?Medline (NASDAQ:MDLN) - Benzinga

Analysts Say Medline Has The Secret Sauce For Sustained Growth - Sahm

Is Medline (MDLN) Fairly Priced After Recent Share Price Stability? - Yahoo Finance

Analysts initiate Medline with bullish ratings after blockbuster IPO - Reuters

TD Cowen initiates Medline stock with Buy rating on market share growth - Investing.com Nigeria

BTIG initiates coverage on Medline stock with Buy rating, $50 target By Investing.com - Investing.com South Africa

Wells Fargo & Company Begins Coverage on Medline (NASDAQ:MDLN) - MarketBeat

This Netflix Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Medline initiated with a Buy at BTIG - TipRanks

Goldman Sachs Initiates Coverage on Medline With Buy Rating, $49 Price Target - marketscreener.com

BMO Capital Initiates Coverage on Medline With Outperform Rating, $45 Price Target - marketscreener.com

JPMorgan Initiates Coverage on Medline With Overweight Rating, $50 Price Target - marketscreener.com

William Blair initiates Medline stock with Outperform rating By Investing.com - Investing.com South Africa

Medline Inc (MDLN) 재무 분석

매출

순이익

현금흐름

주당 순 이익

Medline Inc 주식 (MDLN) 내부자 거래

MDLN과 유사한 종목